Penumbra Financial Ratios
NYSE: PENHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Penumbra ratio analysis
Penumbra earned a net margin of 12.7% in FY 2025, up from 1.2% a year earlier. Gross margin was 67.1% compared with a median of 64.5% over the prior 9 years. Return on equity reached 12.4%, meaning Penumbra generated 0.12 dollars of profit for every dollar of shareholders' equity.
At the end of FY 2025, PEN traded at 68.5 times earnings; across the 8 fiscal years shown, its year-end P/E ranged from 68.5 to 2052.3, with a median of 408.6. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Penumbra financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 68.46 | 672.14 | 108.42 | — | 2,052.29 | — | 119.92 | 685.56 | 723.85 | 145.00 |
| Price / sales | 8.58 | 7.83 | 9.13 | 9.94 | 14.13 | 11.17 | 10.20 | 9.47 | 9.30 | 7.38 |
| Price / book | 8.44 | 8.12 | 8.19 | 8.43 | 11.07 | 9.76 | 11.49 | 9.98 | 7.75 | 7.29 |
| Gross margin | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% | 60.3% | 68.0% | 65.7% | 65.1% | 64.9% |
| Operating margin | 13.5% | 0.8% | 6.9% | 0.7% | -1.0% | -6.9% | 8.7% | -0.2% | 0.3% | -0.5% |
| Net margin | 12.7% | 1.2% | 8.6% | -0.2% | 0.7% | -2.8% | 8.9% | 1.5% | 1.4% | 5.6% |
| Free cash flow margin | 12.5% | 12.3% | 7.8% | -8.8% | -1.6% | -10.3% | 0.8% | 4.3% | 0.0% | -10.0% |
| Return on equity (ROE) | 12.4% | 1.2% | 7.7% | -0.2% | 0.6% | -2.4% | 10.0% | 1.6% | 1.2% | 5.6% |
| Return on assets (ROA) | 9.7% | 0.9% | 5.8% | -0.1% | 0.4% | -1.9% | 7.3% | 1.3% | 1.0% | 4.8% |
| Current ratio | 6.64 | 6.01 | 6.06 | 5.21 | 5.53 | 5.83 | 5.09 | 6.22 | 7.41 | 7.37 |
| Revenue growth | 17.5% | 12.9% | 25.0% | 13.3% | 33.4% | 2.4% | 23.0% | 33.3% | 26.8% | 41.5% |
| EPS growth | 1,155.6% | -84.5% | — | -135.7% | — | -132.8% | 644.4% | 38.5% | -70.5% | 450.0% |